IRIS
PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.687
EU - Europa 2.086
AS - Asia 1.866
SA - Sud America 254
AF - Africa 231
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.600
RU - Federazione Russa 1.205
SG - Singapore 984
CN - Cina 473
IT - Italia 329
BR - Brasile 210
IE - Irlanda 191
CI - Costa d'Avorio 147
VN - Vietnam 137
KR - Corea 85
DE - Germania 71
GB - Regno Unito 69
CA - Canada 53
UA - Ucraina 49
IN - India 45
NL - Olanda 38
HK - Hong Kong 32
PL - Polonia 26
MX - Messico 25
SN - Senegal 25
JP - Giappone 24
FI - Finlandia 23
BJ - Benin 22
SE - Svezia 18
AR - Argentina 17
BD - Bangladesh 17
ES - Italia 17
CZ - Repubblica Ceca 16
ZA - Sudafrica 16
NG - Nigeria 14
ID - Indonesia 12
IQ - Iraq 12
FR - Francia 9
TR - Turchia 9
CH - Svizzera 8
CO - Colombia 6
PE - Perù 6
EC - Ecuador 5
PY - Paraguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
IR - Iran 4
LT - Lituania 4
AT - Austria 3
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
MA - Marocco 3
SA - Arabia Saudita 3
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LB - Libano 2
PK - Pakistan 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
QA - Qatar 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
Totale 7.128
Salva come PNG Salva come JPEG
Città #
Singapore 612
Moscow 594
Santa Clara 473
Dallas 421
Ashburn 205
Dublin 191
Chandler 179
Hefei 170
Los Angeles 149
Abidjan 147
Chicago 108
Seoul 84
Beijing 76
Boardman 69
New York 67
Civitanova Marche 65
Ho Chi Minh City 51
Cambridge 50
Jacksonville 50
Lawrence 50
Catania 48
Andover 38
Buffalo 37
Hong Kong 31
São Paulo 29
Nanjing 28
Amsterdam 27
Bremen 26
Dakar 25
Des Moines 24
Tokyo 24
Warsaw 24
Denver 23
Cotonou 22
Hanoi 22
Brooklyn 21
Orem 20
Toronto 20
Lappeenranta 18
Poplar 18
Chennai 17
Milan 17
Saint Petersburg 17
Stockholm 17
Wilmington 15
Abuja 14
London 14
Rome 14
Brno 13
Haiphong 12
Houston 12
San Francisco 12
Council Bluffs 11
Johannesburg 11
Manchester 11
Montreal 11
Phoenix 11
Washington 11
Atlanta 10
Mexico City 10
Nanchang 9
Boston 8
Querétaro 8
Ankara 7
Baghdad 6
Frankfurt am Main 6
Mumbai 6
Redwood City 6
Rio de Janeiro 6
San Jose 6
Shenyang 6
Arequipa 5
Calgary 5
Genoa 5
Hebei 5
Messina 5
Munich 5
Palermo 5
Redondo Beach 5
San Mateo 5
Tianjin 5
Turin 5
Turku 5
Bernareggio 4
Bắc Ninh 4
Changsha 4
Columbus 4
Da Nang 4
Dhaka 4
Dong Ket 4
Misterbianco 4
Pune 4
Seattle 4
Tehran 4
The Dalles 4
Bari 3
Bishkek 3
Brussels 3
Charlotte 3
Curitiba 3
Totale 4.793
Salva come PNG Salva come JPEG
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 119
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 115
Lung clearance index: A new measure of late lung complications of cancer therapy in children 111
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 111
Minor pulmonary malformations in a child 110
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 109
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 108
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 108
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 107
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 105
Biomarkers in pediatric lung diseases including cystic fibrosis 104
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 102
Lactoferrin: Cytokine modulation and application in clinical practice 101
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 101
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 100
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 99
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 99
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 99
Hypertransaminasemia in children is not always as simple as it seems 99
Cetirizine use in childhood: An update of a friendly 30-year drug 98
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 96
Serum YKL-40 in children with asthma 94
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 94
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 93
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 92
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 91
Novel therapeutic targets for allergic airway disease in children 91
HMGB1 values and response to HBV vaccine in children with celiac disease 90
Antihistamines: ABC for the pediatricians 90
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 89
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 87
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 86
Antihistamines in children and adolescents: A practical update 85
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 82
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 81
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 81
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 81
Lung clearance index for evaluation of late complications of cancer therapy in children 80
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 80
Exhaled breath temperature in astmatic children 79
Severe Kawasaki disease in a 3-month-old patient: a case report. 77
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 77
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 76
Liver disease in Cystic Fibrosis: an update 75
Genetic disorders of surfactant deficiency and neonatal lung disease 74
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 73
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 72
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 72
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 71
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 71
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 71
Severe disease in Cystic Fibrosis and fecal calprotectin levels 71
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 71
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 70
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 69
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 68
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 65
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 65
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 64
Impact of COVID-19 on the management of patients with Lysosomal Storage Disorders 63
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial Cells 63
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 62
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 61
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 61
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 60
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 60
The immunomodulatory role of vitamin D in respiratory diseases 58
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 58
Lower airway microbiota 57
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 57
The role of skin infections in atopic dermatitis in children 56
Upper and lower airways diseases in childhood 56
Type 2 inflammation in cystic fibrosis: New insights 55
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 51
Protracted bacterial bronchitis: more to know 50
Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic Management 49
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 49
Nasal microbiome in chronic rhinosinusitis 48
HMGB1 as a Biomarker of Inhaled Corticosteroid Treatment Response in Moderate-Severe Asthmatic Children: A Single Center Pilot Study 44
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 39
Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review 38
Observational study of sleep-related breathing disorders and preventive non-invasive ventilation in cystic fibrosis 38
Pidotimod in allergic diseases 38
Correlation between RINT values and echocardiographic indices in pre-school children with chronic cough and wheezing 35
Oral immunotherapy in children with allergic diseases: past, present and future 35
Efficacy of sublingual allergen-specific immunotherapy in children evaluated by the measurements of bronchial and nasal nitric oxide. Preliminary results 35
Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators 33
Calprotectin in cystic fibrosis: A new marker of flogosis 32
COVID-19 ocular manifestation in children 32
Three Consecutive Cases of Double Aortic Arch with Various Clinical Onset 30
Effectiveness of omalizumab in two children with severe vernal keratoconjunctivitis 29
Corrigendum to “Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor”. J Pediatr. 2024 Jun 28; 274:114176 29
Evaluation of Oxidative Stress Degree in Patients Affected by Cystic Fibrosis or Non-CF Bronchiectasis through the Measurement of 8-isoprostane 28
Plasmatic Amino Acids in Patients with Cystic Fibrosis: An Observational Study 27
Measurement of nitric oxide and assessment of airway diseases in children: An update 27
Lobar Emphysema in a 7-year-old girl: Acquired Form or Late Onset Congenital Form? 27
Influence of early growth on childhood lung function assessed by magnetic resolution imaging and spirometry. The Generation R Study 27
Fever and tick-borne disease 25
COVID-19 Pneumonia in Children: From Etiology to Management 25
An overview of HMGB1 and its potential role as a biomarker for RSV infection 25
Totale 6.971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.625 47 188 68 112 292 310 48 33 75 148 163 141
2025/20264.013 265 330 595 366 1.056 1.401 0 0 0 0 0 0
Totale 7.299